项目编号 PRJCA024983
项目标题 CHOICE01-ctDNA
涉及领域 Medical
数据类型 Variation
物种名称 Homo sapiens
描述信息 CHOICE-01 was a multicentered, randomized, placebo-controlled, double-blinded phase III trial conducted in 59 medical centers across China, assessing the efficacy and safety of chemotherapy plus toripalimab, an anti-PD-1 antibody, in treatment-naive patients with locally advanced (Stage IIIB or IIIC) or metastatic NSCLC without EGFR or ALK driver mutations.
样品范围 Multiisolate
发布日期 2024-04-06
项目资金来源
机构 项目类型 授权项目ID 授权项目名称
National Natural Science Foundation of China (NSFC) 82272796
提交者 Jie Wang (zlhuxi@163.com)
提交单位 National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences
提交日期 2024-04-06

项目包含数据信息

资源名称 描述
BioSample (654)  show -